This content is restricted.
Brief
"On 27/11/2024, the Italian Medicines Agency (AIFA) issued an update regarding AIFA Board of Directors approves the reimbursability of 16 medicines. The approved medicines include 14 active principles, three orphan drugs for rare diseases, seven new molecules, and six extensions of therapeutic indications."
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested